Please sign in to follow a disease.
Peritoneal mesothelioma
MONDO:0006362A benign or malignant mesothelial neoplasm that arises from the peritoneum.
Also known as: mesothelioma of peritoneum, mesothelioma of the peritoneum, peritoneal mesothelioma, peritoneal mesothelioma (disease), peritoneum mesothelioma
1447 clinical trials for this condition and its sub-types, 14 tagged with Peritoneal mesothelioma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Peritoneal mesothelioma
-
Malignant peritoneal mesothelioma 13 trials
-
Benign peritoneal mesothelioma 0 trials
-
Peritoneal mesothelioma in situ 0 trials
-
Peritoneal multicystic mesothelioma 0 trials
-
New immunotherapy combo targets rare cancers left behind by progress
Disease control OngoingThis phase 2 trial tests a combination of two immunotherapy drugs, domvanalimab and zimberelimab, in people with five types of advanced rare cancers (peritoneal mesothelioma, gestational trophoblastic tumor, anaplastic thyroid carcinoma, neuroendocrine tumors, and thymic carcinom…
Phase 2 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New drug XmAb20717 tested in rare cancers – trial suspended
Disease control PausedThis phase II trial tests the safety and effectiveness of a drug called XmAb20717 in 140 people with advanced rare cancers, including mesothelioma, lymphoma, and small cell lung cancer. The drug is given by IV. The main goal is to see if tumors shrink. The trial is currently susp…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New combo therapy targets rare abdominal cancer
Disease control PausedThis study tests whether adding a special chemotherapy spray (PIPAC) directly into the abdomen to standard IV chemo can help people with a rare cancer of the belly lining (peritoneal mesothelioma) live longer. About 66 adults who have not had prior treatment will be randomly assi…
Phase 2 • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC